§16-51-4. Drug Manufacturers; Availability of Investigational Drugs, Biological Products or Devices; Costs; Insurance Coverage
(a) A manufacturer of an investigational drug, biological product or device may make available the manufacturer’s investigational drug, biological product or device to eligible patients pursuant to this article. This article does not require that a manufacturer make available an investigational drug, biological product or device to an eligible patient. (b) A manufacturer may: (1) […]
§16-51-5. Action Against Health Care Provider’s License or Medicare Certification Prohibited
Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend or take any action against a health care provider’s license issued pursuant to chapter thirty of this code based solely on the health care provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product […]
§16-51-6. Access to Investigational Drugs, Biological Products and Devices
An official, employee or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological product or device. Counseling, advice or a recommendation consistent with medical standards of care from a licensed health care provider is not a violation of this section.
§16-51-7. No Cause of Action Created
This article does not create a private cause of action against a manufacturer of an investigational drug, biological product or device, against a health care provider as defined in section two, article seven-b, chapter fifty-five of this Code, or against any other person or entity involved in the care of an eligible patient using the […]
§16-51-8. Effect on Health Care Coverage
Nothing in this article affects the mandatory health care coverage for participation in clinical trials pursuant to section two, article twenty-five-f, chapter thirty-three of this code.
§16-52-1. Findings and Purpose
[Repealed.]
§16-52-2. Creation of the Coalition for Responsible Chronic Pain Management
[Repealed.]
§16-52-3. Members of the Coalition for Responsible Chronic Pain Management
[Repealed.]
§16-51-1. Short Title
This article shall be known and may be cited as the Ben Price Right to Try Act.
§16-50-2. Authority
The department may: (1) Propose legislative rules for legislative approval in accordance with the provisions of article three, chapter twenty-nine-a of this code, necessary to administer this article; and